{"nct_id":"NCT03222609","title":"A Study Evaluating Tolerability and Efficacy of Navitoclax Alone or in Combination With Ruxolitinib in Participants With Myelofibrosis","status":"COMPLETED","status_verified_date":"2025-02","start_date":"2017-10-31","start_date_type":"ACTUAL","primary_completion_date":"2022-03-28","primary_completion_date_type":"ACTUAL","completion_date":"2025-01-29","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["ABBV"]}